<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-101794</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Positive assessment of drugs: 1st trimester 2012</dc:title>
<dc:description xml:lang="en">The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the first trimester of 2012, and considered of interest in hospital healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU)</dc:description>
<dc:creator>Prats Oliván, P</dc:creator>
<dc:creator>González Alfonso, M</dc:creator>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Puerro Vicente, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en el 1er trimestre de 2012, y considerados de mayor interés para el profesional sanitario en el ámbito hospitalario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;68(2): 106-108, abr.-jun. 2012.</dc:source>
<dc:identifier>ibc-101794</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: 1er trimestre 2012</dc:title>
<dc:subject>^d22676^s22073</dc:subject>
<dc:subject>^d30516^s22002</dc:subject>
<dc:subject>^d31432^s22073</dc:subject>
<dc:subject>^d35367^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24613^s22002</dc:subject>
<dc:subject>^d32861^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201206</dc:date>
</metadata>
</record>
</ibecs-document>
